APSO Opens Audiology Assistant Standard for Public Review and Comment
The Audiology Practice Standards Organization is inviting US audiologists to review and comment on a proposed national standard for audiology assistants through November 6, 2026.
The Audiology Practice Standards Organization is inviting US audiologists to review and comment on a proposed national standard for audiology assistants through November 6, 2026.
Neuromod Devices has achieved both Medical Device Single Audit Program (MDSAP) and EU Medical Device Regulation (MDR) certification, enabling expanded global availability of its Lenire tinnitus treatment device in Europe, Canada, Australia, and beyond.
Sens Chuck Grassley (R-Iowa) and Elizabeth Warren (D-Mass) released the findings of their new bipartisan investigative report: Loud and Clear: Why Americans Want Effective and Affordable Over-the-Counter Hearing Aids – and How Powerful Special Interests are Trying to Undermine Them.
The Healthcare Equality Network (HEN)—a group advocating for equal, quality access to healthcare for Black Americans—recently wrote a letter to the Food and Drug Administration (FDA) proposing changes to the OTC Hearing Aid Rule.
Read MoreIn a letter to US Food and Drug Administration (FDA) Acting Commissioner Janet Woodcock, Sens. Chuck Grassley (R-Iowa) and Elizabeth Warren (D-Mass.) expressed their support for key provisions in the FDA’s proposed rule for regulating over-the-counter (OTC) hearing aids.
Read MoreA statement from Starkey President Brandon Sawalich addresses President Biden’s announcement about the White House Competition Council, which was established by the July 2021 Promoting Competition in the American Economy executive order advancing US economic competition.
Read MoreEargo, Inc (Nasdaq: EAR), a medical device company on a mission to improve the quality of life of people with hearing loss, announced the submission of public comments to the Food and Drug Administration (FDA) concerning its proposed rule to create a new regulatory category of over the counter (OTC) hearing aids.
Read MoreThe Hearing Loss Association of America (HLAA) announced that it filed comments to the Food and Drug Administration (FDA) on its proposed rule establishing Over-the-Counter (OTC) hearing aids. Once finalized by the FDA, consumers 18 and older with mild-to- moderate hearing loss will be able to purchase hearing aids at retail and online outlets.
Read MoreThe National Association of Attorneys General (NAAG) cautions that OTC hearing aid rules currently under review by the FDA may unintentionally hinder or repeal important consumer protection authorities, undermining states’ ability to ensure safe and affordable access to hearing aids. Currently, all 50 states have hearing professional licensing requirements and many have important protections for hearing aid consumers, including advertising restrictions, as well as mandatory warrantees and returns.
Read MoreThe settlement resolves a complaint by a deaf patient who alleged that despite her requests for an American Sign Language (ASL) interpreter for her labor and delivery, Advent failed to provide an interpreter or any other communication aid or service.
Read MoreThe US Department of Justice (DOJ) and Kaiser Foundation Health Plan of Washington (KFHPW), resolved allegations from several complainants that it repeatedly failed to provide interpreters to patients who are deaf or deaf-blind, in violation of the “Americans with Disabilities Act (ADA),” announced US Attorney Nicholas W. Brown.
Read MoreThe 114-page rules document published today in the Federal Register covers most aspects related to OTC hearing aid manufacturing, electroacoustic requirements, packaging and labeling, returns, and conditions for sale. In an effort to promote more consistency in the regulations and enforcement of hearing aid manufacturing and distribution, the FDA is also proposing several important changes that could affect the industry and state-wide hearing aid dispensing.
Read MoreStarkey President and CEO Brandon Sawalich has issued a statement regarding the recent proposed ruling by the Federal Food and Drug Administration (FDA) outlining a new category of hearing aids that can be sold over the counter (OTC).
Read MoreTo ensure patient safety, the proposed rule addresses maximum output limits and includes certain device performance and design requirements, such as distortion control limits, self-generated noise limits, latency limits, frequency bandwidth, as well as a requirement to limit the insertion depth of the device. The proposed rule also includes labeling requirements for OTC hearing aids. As hoped, the FDA also issued an updated draft guidance, “Regulatory Requirements for Hearing Aid Devices and Personal Sound Amplification Products (PSAPs).”
Read MoreStarkey announced the launch of Listen Carefully, an initiative aimed at “bridging the conversation between hearing healthcare providers and lawmakers in Washington, DC.”
Read MoreAn opinion article published on the data intelligence company Morning Consult’s website by Starkey President Brandon Sawalich discusses some “misconceptions about hearing aids” following President Biden’s recent executive order on competition.
Read MoreIn an article recently published on the “Forbes” website, Starkey CEO Brandon Sawalich discusses the three guiding principles he follows with regard to the hearing care industry and the company’s dedication to providing people with better hearing
Read MoreOn July 9, 2021, President Biden unveiled an executive order unveiling 72 initiatives that included, among other things, plans to allow hearing aids to be sold over the counter at pharmacies.
Read More